RETRACTION: Circular RNA SMARCA5 May Serve as a Tumor Suppressor in Non-Small Cell Lung Cancer. [PDF]
J Clin Lab Analeuropepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller +14 more
wiley +1 more source
RETRACTION: Value of Circular RNA 0007385 in Disease Monitoring and Prognosis Estimation in Non-Small-Cell Lung Cancer Patients. [PDF]
J Clin Lab Analeuropepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw +5 more
wiley +1 more source
RETRACTION: Potentiality of Forkhead Box Q1 as a Biomarker for Monitoring Tumor Features and Predicting Prognosis in Non-Small Cell Lung Cancer. [PDF]
J Clin Lab Analeuropepmc +1 more source
Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito +8 more
wiley +1 more source
RETRACTION: Polo-Like Kinase 4 Correlates With Greater Tumor Size, Lymph Node Metastasis, and Confers Poor Survival in Non-Small Cell Lung Cancer. [PDF]
J Clin Lab Analeuropepmc +1 more source
RETRACTION: Katanin P80 as a Prognostic Biomarker Associated With Tumor Progression in Non-Small-Cell Lung Cancer. [PDF]
J Clin Lab Analeuropepmc +1 more source
RETRACTION: Guanylate-Binding Protein 1 Correlates With Advanced Tumor Features and Serves as a Prognostic Biomarker for Worse Survival in Lung Adenocarcinoma Patients. [PDF]
J Clin Lab Analeuropepmc +1 more source